Skip to main content

previous disabled Page of 3
and
  1. Article

    Open Access

    Author Correction: Prospective individual patient data meta-analysis of two randomized trials on convalescent plasma for COVID-19 outpatients

    Pere Millat-Martinez, Arvind Gharbharan, Andrea Alemany in Nature Communications (2024)

  2. Article

    Open Access

    Immunization with V987H-stabilized Spike glycoprotein protects K18-hACE2 mice and golden Syrian hamsters upon SARS-CoV-2 infection

    Safe and effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines are crucial to fight against the coronavirus disease 2019 pandemic. Most vaccines are based on a mutated version of the ...

    Carlos Ávila-Nieto, Júlia Vergara-Alert, Pep Amengual-Rigo in Nature Communications (2024)

  3. Article

    Open Access

    Male genitourinary schistosomiasis-related symptoms among long-term Western African migrants in Spain: a prospective population-based screening study

    Schistosomiasis is highly endemic in sub-Saharan Africa and frequently imported to Europe. Male urogenital manifestations are often neglected. We aimed to ascertain the prevalence of genitourinary clinical sig...

    Sílvia Roure, Xavier Vallès, Olga Pérez-Quílez in Infectious Diseases of Poverty (2024)

  4. Article

    Open Access

    Immunisation efficacy of a stabilised SARS-CoV-2 spike glycoprotein in two geriatric animal models

    Age is associated with reduced efficacy of vaccines and linked to higher risk of severe COVID-19. Here we determined the impact of ageing on the efficacy of a SARS-CoV-2 vaccine based on a stabilised Spike gly...

    Carla Usai, Erola Ainsua-Enrich, Victor Urrea Gales, Edwards Pradenas in npj Vaccines (2024)

  5. Article

    Open Access

    SAMHD1 expression is a surrogate marker of immune infiltration and determines prognosis after neoadjuvant chemotherapy in early breast cancer

    The lack of validated surrogate biomarkers is still an unmet clinical need in the management of early breast cancer cases that do not achieve complete pathological response after neoadjuvant chemotherapy (NACT...

    Lucía Gutiérrez-Chamorro, Eudald Felip, Eva Castellà, Vanessa Quiroga in Cellular Oncology (2024)

  6. Article

    Open Access

    Virus-like particle-mediated delivery of structure-selected neoantigens demonstrates immunogenicity and antitumoral activity in mice

    Neoantigens are patient- and tumor-specific peptides that arise from somatic mutations. They stand as promising targets for personalized therapeutic cancer vaccines. The identification process for neoantigens ...

    Ana Barajas, Pep Amengual-Rigo, Anna Pons-Grífols in Journal of Translational Medicine (2024)

  7. Article

    Open Access

    Self-sampling monkeypox virus testing in high-risk populations, asymptomatic or with unrecognized Mpox, in Spain

    The recent monkeypox virus (MPXV) outbreak was of global concern and has mainly affected gay, bisexual and other men who have sex with men (GBMSM). Here we assess prevalence of MPXV in high-risk populations of...

    Cristina Agustí, Héctor Martínez-Riveros in Nature Communications (2023)

  8. Article

    Open Access

    Safety and immunogenicity of a recombinant protein RBD fusion heterodimer vaccine against SARS-CoV-2

    In response to COVID-19 pandemic, we have launched a vaccine development program against SARS-CoV-2. Here we report the safety, tolerability, and immunogenicity of a recombinant protein RBD fusion heterodimeri...

    Lorna Leal, Judit Pich, Laura Ferrer, Jocelyn Nava, Ruth Martí-Lluch in npj Vaccines (2023)

  9. Article

    Open Access

    Alanine-based spacers promote an efficient antigen processing and presentation in neoantigen polypeptide vaccines

    Neoantigens are tumor-specific antigens that are mostly particular for each patient. Since the immune system is able to mount a specific immune response against these neoantigens, they are a promising tool for...

    Carmen Aguilar-Gurrieri, Ana Barajas, Carla Rovirosa in Cancer Immunology, Immunotherapy (2023)

  10. Article

    Open Access

    An engineered HIV-1 Gag-based VLP displaying high antigen density induces strong antibody-dependent functional immune responses

    Antigen display on the surface of Virus-Like Particles (VLPs) improves immunogenicity compared to soluble proteins. We hypothesised that immune responses can be further improved by increasing the antigen densi...

    Ferran Tarrés-Freixas, Carmen Aguilar-Gurrieri in npj Vaccines (2023)

  11. Article

    Open Access

    Author Correction: Modulation of the autophagic pathway inhibits HIV-1 infection in human lymphoid tissue cultured ex vivo

    Sònia Pedreño‑López, Elisabet García, Dolores Guerrero in Scientific Reports (2023)

  12. Article

    Open Access

    Identifying the needs of older people living with HIV (≥ 50 years old) from multiple centres over the world: a descriptive analysis

    Older People Living with HIV (OPWH) combine both aging and HIV-infection features, resulting in ageism, stigma, social isolation, and low quality of life. This context brings up new challenges for healthcare p...

    Tomás Martín Grosso, Diana Hernández-Sánchez, Gordana Dragovic in AIDS Research and Therapy (2023)

  13. Article

    Open Access

    Monitoring SARS-CoV-2 variant transitions using differences in diagnostic cycle threshold values of target genes

    Monitoring the emergence of new SARS-CoV-2 variants is important to detect potential risks of increased transmission or disease severity. We investigated the identification of SARS-CoV-2 variants from real-tim...

    Antoni E. Bordoy, Verónica Saludes, David Panisello Yagüe in Scientific Reports (2022)

  14. Article

    Safety, immunogenicity and effect on viral rebound of HTI vaccines in early treated HIV-1 infection: a randomized, placebo-controlled phase 1 trial

    HIVACAT T-cell immunogen (HTI) is a novel human immunodeficiency virus (HIV) vaccine immunogen designed to elicit cellular immune responses to HIV targets associated with viral control in humans. The AELIX-002...

    Lucia Bailón, Anuska Llano, Samandhy Cedeño, Tuixent Escribà in Nature Medicine (2022)

  15. Article

    Open Access

    Kinetics of humoral immune response over 17 months of COVID-19 pandemic in a large cohort of healthcare workers in Spain: the ProHEpiC-19 study

    Understanding the immune response to the SARS-CoV-2 virus is critical for efficient monitoring and control strategies. The ProHEpic-19 cohort provides a fine-grained description of the kinetics of antibodies a...

    Concepción Violán, Pere Torán-Monserrat, Bibiana Quirant in BMC Infectious Diseases (2022)

  16. Article

    Open Access

    Glucocorticoids’ treatment impairs the medium-term immunogenic response to SARS-CoV-2 mRNA vaccines in Systemic Lupus Erythematosus patients

    Limited data exists on SARS-CoV-2 sustained-response to vaccine in patients with rheumatic diseases. This study aims to evaluate neutralizing antibodies (nAB) induced by SARS-CoV-2 vaccine after 3 to 6 months ...

    Silvia Garcia-Cirera, Joan Calvet, Antoni Berenguer-Llergo in Scientific Reports (2022)

  17. Article

    Open Access

    Author Correction to: SARS-CoV-2 interaction with Siglec-1 mediates trans-infection by dendritic cells

    Daniel Perez-Zsolt, Jordana Muñoz-Basagoiti, Jordi Rodon in Cellular & Molecular Immunology (2022)

  18. Article

    Open Access

    Prevalence of HPV-DNA and E6 mRNA in lung cancer of HIV-infected patients

    HIV-infected individuals could be at a greater risk for develo** lung cancer than the general population due to the higher prevalence in the former of human papillomavirus (HPV) in the oral cavity and higher...

    Guillem Sirera, Sebastián Videla, Verónica Saludes, Eva Castellà in Scientific Reports (2022)

  19. Article

    Open Access

    Prospective individual patient data meta-analysis of two randomized trials on convalescent plasma for COVID-19 outpatients

    Data on convalescent plasma (CP) treatment in COVID-19 outpatients are scarce. We aimed to assess whether CP administered during the first week of symptoms reduced the disease progression or risk of hospitaliz...

    Pere Millat-Martinez, Arvind Gharbharan, Andrea Alemany in Nature Communications (2022)

  20. Article

    Open Access

    Modulation of the autophagic pathway inhibits HIV-1 infection in human lymphoid tissue cultured ex vivo

    A complex link exists between HIV-1 and autophagy, and discordant results have been reported in different in vitro models regarding the way HIV and autophagy modulate each other. Despite this, there is very li...

    Sònia Pedreño-López, Elisabet García, Dolores Guerrero in Scientific Reports (2022)

previous disabled Page of 3